Effect of Roflumilast 500 μg Tablets Once Daily at Acute COPD Exacerbations Treated With Standard Therapy of Oral Steroids and Antibiotics. A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008192/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to investigate if roflumilast can reduce the neutrophilic
inflammation at acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). In
addition, the potential benefit of roflumilast on severity and recovery periods of acute COPD
exacerbations will be assessed using patient diaries and questionnaires.
提供机构：
Vivli
创建时间：
2022-07-06
